StockScouter

The StockScouter® System is a proprietary stock scoring model which covers U.S. companies listed on the major exchanges. The 10 (best) to 1 (worst) score is derived from Fundamental, Technical, Ownership, and Valuation sub-models in combination with a Risk model which assesses the expected risk and return.

StockScouter Screening Tool StockScouter Top 50

TCRR TCR2 THERAPEUTICS INCORPORATED StockScouter® Report

4

StockScouter® Score

TCR2 THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to perform in line with the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral

 

Concerns

  • The 50-day moving average for TCRR is below its 200-day moving average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 100% done.
Progress: 60% done.
Low
High

Core Model Grades

B
C
N/A
C

Previous Ratings

 

Disclaimer: StockScouter is a registered trademark of Verus Analytics, Inc. All Verus Analytics materials available through this site are published solely for informational purposes and are not to be construed as advice or a recommendation to specific individuals. Individuals should take into account their personal financial circumstances in acting on any rankings or stock selections provided by Verus Analytics. Verus Analytics makes no representations that the techniques used in its rankings or selections will result in or guarantee profits in trading. Trading involves risk, including possible loss of principal and other losses, and past performance is no indication of future results. Verus Analytics may have previously distributed the information in its reports and analyses in different forms. The owners and executives of Verus Analytics and its partners 1) may own individual stocks rated by the StockScouter system, 2) have no influence on the ratings, and 3) do not act on ratings changes before they are made publicly available.